We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Tobacco Smoke and Atherosclerosis Progression

Carr J. Smith, PhD, DABT; Michael W. Ogden, PhD
JAMA. 1998;280(1):32-33. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-1-jbk0701.
Text Size: A A A
Published online


To the Editor.— Dr Howard et al1 conclude, "Atherosclerosis progression appears to be largely related to the pack-years of cigarette exposure and not to present smoking status" and "the impact of exposure to ETS [environmental tobacco smoke] was 34% (5.9/17.1) as great as the impact of active smoking on the progression of atherosclerosis." The first conclusion is in stark contradiction with 2 huge bodies of literature, the mechanisms underlying the atherosclerotic process2 and measured alterations in atherogenic and atherothrombotic markers of risk seen in current smokers but not in ex-smokers. Many studies in current smokers, but not ex-smokers, have reported elevated low-density lipoprotein cholesterol levels and lower high-density lipoprotein cholesterol levels; increased fibrinogen levels; acute platelet aggregation and peripheral white blood cell counts; transient increases in blood pressure, heart rate, and vasoconstriction; increased blood viscosity via elevations in red blood cells, hematocrit, and hemoglobin; and increases in oxidative stress. In summary, the growth rate of plaque in ex-smokers would be expected to be less than the plaque growth rate found in smokers currently experiencing the large number of atherogenic stimuli listed above. If the normalization of these changes in ex-smokers has no impact on the progression of atherosclerosis, then a conceptual paradigm shift regarding the biochemical and hemodynamic stimuli of atherosclerotic plaque growth is in order.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.